Cargando…

Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The newly introduced non-thermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and comparable safety features. However, previous studies have show...

Descripción completa

Detalles Bibliográficos
Autores principales: Woermann, J, Schipper, J, Lueker, J, Van Den Bruck, J, Filipovic, K, Erlhoefer, S, Pavel, F, Scheuerlen, C, Dittrich, S, Steven, D, Sultan, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206879/
http://dx.doi.org/10.1093/europace/euad122.095
_version_ 1785046323020431360
author Woermann, J
Schipper, J
Lueker, J
Van Den Bruck, J
Filipovic, K
Erlhoefer, S
Pavel, F
Scheuerlen, C
Dittrich, S
Steven, D
Sultan, A
author_facet Woermann, J
Schipper, J
Lueker, J
Van Den Bruck, J
Filipovic, K
Erlhoefer, S
Pavel, F
Scheuerlen, C
Dittrich, S
Steven, D
Sultan, A
author_sort Woermann, J
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The newly introduced non-thermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and comparable safety features. However, previous studies have shown that high power short duration ablation (HPSD) is also highly effective and fast to achieve PVI with potentially less AF recurrence. Data comparing PFA to HPSD-PVI is lacking. OBJECTIVE: This study compared procedural parameter and outcome using the novel PFA-PVI to HPSD-PVI in patients with paroxysmal or persistent atrial fibrillation (PAF/persAF). METHODS: Between 09/2021 and 10/2022 all consecutive patients undergoing de-novo PVI (PFA or HPSD) were included in this analysis. For PFA-PVI a shapeable (flower/basket shape) 5 spline 20 electrode catheter was used. For HPSD-PVI a power setting of 70W/7s (70W/5s at posterior wall) was considered as HPSD. Furthermore, a 3D mapping system was used. Follow-up consisted of out-clinic pts visit, teleconsultation, 48h Holter ECG and CIED interrogation if applicable. RESULTS: A total of 114 patients (57 PFA [17(30%) PAF; 40(70%) persAF 40(70%)] were included in this analysis. PVI was successful in all patients. The PFA group revealed a significantly shorter procedure duration (65±17 min vs. 95±23 min, p<0.01) but longer fluoroscopy time (PFA 15±5min and HPSD 12±3min; p<0.001). However, the overall fluoroscopy dosage was comparable between groups (PFA: 3484±2072mGy*cm2; HPSD: 3168±2346mGy*cm2; p=0.448). Two tamponades occurred in the PFA while in HPSD two pts suffered groin bleedings. At follow-up after three months (33±12 days) 46 PFA (80.7%) and 44 HPSD pts (77.2%) were free from atrial arrhythmia after a single procedure (p=0.819). One clinically non.significant PV stenosis occurred in the HPSD group. CONCLUSION: PFA and HPSD-PVI seem to be highly effective and safe to achieve PVI in the setting of PAF and persAF with comparable arrhythmia free survival. However, procedure duration for PFA PVI is significantly shorter and therefore may be of potential benefit.
format Online
Article
Text
id pubmed-10206879
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102068792023-05-25 Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation Woermann, J Schipper, J Lueker, J Van Den Bruck, J Filipovic, K Erlhoefer, S Pavel, F Scheuerlen, C Dittrich, S Steven, D Sultan, A Europace 10.4.5 - Rhythm Control, Catheter Ablation FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The newly introduced non-thermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and comparable safety features. However, previous studies have shown that high power short duration ablation (HPSD) is also highly effective and fast to achieve PVI with potentially less AF recurrence. Data comparing PFA to HPSD-PVI is lacking. OBJECTIVE: This study compared procedural parameter and outcome using the novel PFA-PVI to HPSD-PVI in patients with paroxysmal or persistent atrial fibrillation (PAF/persAF). METHODS: Between 09/2021 and 10/2022 all consecutive patients undergoing de-novo PVI (PFA or HPSD) were included in this analysis. For PFA-PVI a shapeable (flower/basket shape) 5 spline 20 electrode catheter was used. For HPSD-PVI a power setting of 70W/7s (70W/5s at posterior wall) was considered as HPSD. Furthermore, a 3D mapping system was used. Follow-up consisted of out-clinic pts visit, teleconsultation, 48h Holter ECG and CIED interrogation if applicable. RESULTS: A total of 114 patients (57 PFA [17(30%) PAF; 40(70%) persAF 40(70%)] were included in this analysis. PVI was successful in all patients. The PFA group revealed a significantly shorter procedure duration (65±17 min vs. 95±23 min, p<0.01) but longer fluoroscopy time (PFA 15±5min and HPSD 12±3min; p<0.001). However, the overall fluoroscopy dosage was comparable between groups (PFA: 3484±2072mGy*cm2; HPSD: 3168±2346mGy*cm2; p=0.448). Two tamponades occurred in the PFA while in HPSD two pts suffered groin bleedings. At follow-up after three months (33±12 days) 46 PFA (80.7%) and 44 HPSD pts (77.2%) were free from atrial arrhythmia after a single procedure (p=0.819). One clinically non.significant PV stenosis occurred in the HPSD group. CONCLUSION: PFA and HPSD-PVI seem to be highly effective and safe to achieve PVI in the setting of PAF and persAF with comparable arrhythmia free survival. However, procedure duration for PFA PVI is significantly shorter and therefore may be of potential benefit. Oxford University Press 2023-05-24 /pmc/articles/PMC10206879/ http://dx.doi.org/10.1093/europace/euad122.095 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.4.5 - Rhythm Control, Catheter Ablation
Woermann, J
Schipper, J
Lueker, J
Van Den Bruck, J
Filipovic, K
Erlhoefer, S
Pavel, F
Scheuerlen, C
Dittrich, S
Steven, D
Sultan, A
Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
title Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
title_full Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
title_fullStr Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
title_full_unstemmed Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
title_short Comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
title_sort comparision of pulsed field ablation vs. high power short duration-ablation for pulmonary vein isolation
topic 10.4.5 - Rhythm Control, Catheter Ablation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206879/
http://dx.doi.org/10.1093/europace/euad122.095
work_keys_str_mv AT woermannj comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT schipperj comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT luekerj comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT vandenbruckj comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT filipovick comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT erlhoefers comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT pavelf comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT scheuerlenc comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT dittrichs comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT stevend comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation
AT sultana comparisionofpulsedfieldablationvshighpowershortdurationablationforpulmonaryveinisolation